For: | Nagasawa M. Biomarkers of graft-vs-host disease: Understanding and applications for the future. World J Transplant 2021; 11(8): 335-343 [PMID: 34447670 DOI: 10.5500/wjt.v11.i8.335] |
---|---|
URL: | https://www.wjgnet.com/2220-3230/full/v11/i8/335.htm |
Number | Citing Articles |
1 |
Moisés H. Rojas-Rechy, Félix Gaytán-Morales, Yessica Sánchez-Ponce, Iván Castorena-Villa, Briceida López-Martínez, Israel Parra-Ortega, María C. Escamilla-Núñez, Alfonso Méndez-Tenorio, Ericka N. Pompa-Mera, Gustavo U. Martinez-Ruiz, Ezequiel M. Fuentes-Pananá, Abigail Morales-Sánchez. Herpesvirus Screening in Childhood Hematopoietic Transplant Reveals High Systemic Inflammation in Episodes of Multiple Viral Detection and an EBV Association with Elevated IL-1β, IL-8 and Graft-Versus-Host Disease. Microorganisms 2022; 10(8): 1685 doi: 10.3390/microorganisms10081685
|
2 |
Abhinav Bhattarai, Sangam Shah, Rukesh Yadav, Garima Dhakal, Raksha Neupane, Sunil Paudel, Pragya Bhandari, Hashem Abu Serhan, Ranjit Sah, Sanjit Sah, Joshuan J. Barboza. Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review. Hematology 2024; 29(1) doi: 10.1080/16078454.2023.2293497
|
3 |
Santosh Putta, Bradford A. Young, John E. Levine, Ran Reshef, Ryotaro Nakamura, Christopher Strouse, Miguel-Angel Perales, Alan Howard, Polly Pine, Ju Shi, Peixin Zhang, Vincent T. Ho, Wael Saber. Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study. Transplantation and Cellular Therapy 2023; 29(3): 166.e1 doi: 10.1016/j.jtct.2022.11.024
|
4 |
Santosh Putta, Bradford Young, Polly Pine, Ju Shi, Vian Amber, Wael Saber, John E. Levine, Stephan A. Grupp. Verification of the Prediction Accuracy of a Biomarker-Based Prognostic for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) After Hematopoietic Cell Transplantation (HCT). Transplantation and Cellular Therapy 2024; 30(10): 986.e1 doi: 10.1016/j.jtct.2024.07.010
|
5 |
Robert Zeiser, Olle Ringden, Behnam Sadeghi, Gil Gonen-Yaacovi, Oscar G. Segurado. Novel therapies for graft versus host disease with a focus on cell therapies. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1241068
|
6 |
Vaia-Aikaterini Alexoudi, Eleni Gavriilaki, Angeliki Cheva, Ioanna Sakellari, Stavroula Papadopoulou, Konstantinos Paraskevopoulos, Konstantinos Vahtsevanos. Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?. Pharmaceuticals 2024; 17(3): 298 doi: 10.3390/ph17030298
|
7 |
Masayuki Nagasawa. Pathophysiology of acute graft-versus-host disease from the perspective of hemodynamics determined by dielectric analysis. World Journal of Transplantation 2023; 13(6): 379-390 doi: 10.5500/wjt.v13.i6.379
Abstract(429) |
Core Tip(510) |
Full Article(HTML)(894)
|
Full Article with Cover (PDF)-7039K(58)
|
Full Article (Word)-2517K(22)
|
Audio-1359K(5)
|
Peer-Review Report-180K(38)
|
Answering Reviewers-33K(39)
|
Full Article (PDF)-6740K(71)
|
Full Article (XML)-108K(41)
|
Times Cited (1)
|
Total Visits (4647)
|
Open
|
8 |
Ali Hassan Mushtaq, Areez Shafqat, Haneen T. Salah, Shahrukh K. Hashmi, Ibrahim N. Muhsen. Machine learning applications and challenges in graft-versus-host disease: a scoping review. Current Opinion in Oncology 2023; 35(6): 594 doi: 10.1097/CCO.0000000000000996
|
9 |
Rahma Said, Mohamed Hichem Sellami, Houda Kaabi, Slama Hmida. Minor histocompatibility antigens HA‐8 and PANE1 in the TUNISIAN population. Molecular Genetics & Genomic Medicine 2022; 10(11) doi: 10.1002/mgg3.2050
|